PARATHYROID TUMOUR MALIGNANT

This adverse event was reported 128 times

These drugs are most commonly taken by patients reporting PARATHYROID TUMOUR MALIGNANT:

# Drug Count
0 DENOSUMAB 44
1 CINACALCET 42
2 CINACALCET HYDROCHLORIDE 36
3 ZOLEDRONIC ACID 25
4 CAPECITABINE 16
5 SORAFENIB 16
6 CISPLATIN 15
7 ETOPOSIDE 15
8 TEMOZOLOMIDE 14
9 INTERFERON BETA-1A 9
See all common drugs associated with PARATHYROID TUMOUR MALIGNANT

PARATHYROID TUMOUR MALIGNANT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SEVELAMER HYDROCHLORIDE 1 0.0017
1 PEMIGATINIB 1 0.0012
2 CINACALCET HYDROCHLORIDE 36 0.0008
3 SORAFENIB 16 0.0008
4 ETELCALCETIDE 2 0.0007
5 TEMOZOLOMIDE 14 0.0007
6 ZOLEDRONIC ACID 25 0.0006
7 LOMITAPIDE MESYLATE 2 0.0005
8 SALINE NASAL SPRAY 2 0.0005
9 PAMIDRONATE DISODIUM 1 0.0003
See all drugs enriched for association with PARATHYROID TUMOUR MALIGNANT